Pure Global

Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany - Trial NCT06418646

Access comprehensive clinical trial information for NCT06418646 through Pure Global AI's free database. This phase not specified trial is sponsored by Technische Universität Dresden and is currently Recruiting. The study focuses on Amyotrophic Lateral Sclerosis. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06418646
Recruiting
Trial Details
ClinicalTrials.govNCT06418646
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany

Study Focus

Observational

Sponsor & Location

Technische Universität Dresden

Dresden, Germany

Timeline & Enrollment

N/A

Aug 01, 2022

Jun 30, 2025

500 participants

Primary Outcome

patients' satisfaction with professional care

Summary

The progressive loss of physical functioning resulting from ALS leads also to high
 psychosocial burden for those affected, and organizational challenges related to medical care
 and aids. A multidimensional and -professional care is advised in order to meet the complex
 requirements of this disease. In Germany, medical care structures may not fulfil these high
 requirements, since non-medical services such as psychological support or social counselling
 are not regularly included in care procedures for ALS patients. Specialised palliative care
 is not a standard and still commonly restricted to the last weeks of life. Additionally, it
 is well known that caregivers of ALS patients are highly burdened, but there is a lack of
 support services for them.
 
 By means of a cross-sectional, multicentre survey, we aim to investigate patients' and
 caregivers' perception of medical care for ALS, provided in Germany - with particular regard
 to psychosocial and palliative aspects. The extent to which physical, psychological, social,
 spiritual, practical and informational needs are subjectively met will be assessed and
 correlations with mental wellbeing, subjective quality of life, attitudes towards
 life-sustaining measures and physician-assisted suicide, as well as caregiver burden will be
 examined.
 
 Currently, study planning (questionnaires and ethical approval) is already completed and
 recruitment was started. The study aims to recruit 500 participants from nationwide
 ALS-centres. Cooperating ALS-centres will be recruited via the German Network for Motoneuron
 Diseases (MND-Net), of which our centre is a member. It is intended to provide data-based
 starting points on how care of ALS patients and their caregivers can be improved in Germany,
 in line with their needs.

ICD-10 Classifications

Neuralgic amyotrophy
Motor neuron disease
Other degenerative diseases of the nervous system
Other degenerative disorders of nervous system in diseases classified elsewhere
Multiple sclerosis

Data Source

ClinicalTrials.gov

NCT06418646

Non-Device Trial